585 filings
8-K
PDLI
PDL Biopharma Inc
14 Dec 20
Entry into a Material Definitive Agreement
8:36am
8-K
PDLI
PDL Biopharma Inc
8 Dec 20
PDL Announces Timeline for Voluntarily Delisting from Nasdaq
4:07pm
8-K
PDLI
PDL Biopharma Inc
13 Nov 20
PDL BioPharma Reports 2020 Third Quarter Financial Results and Sets Date To File a Certificate of Dissolution
12:00am
8-K
PDLI
PDL Biopharma Inc
7 Oct 20
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
PDLI
PDL Biopharma Inc
2 Oct 20
PDL BioPharma Completes Spin-Off of LENSAR
8:35am
8-K
v3lt8puxyi utef
10 Sep 20
Regulation FD Disclosure
4:01pm
8-K
i5lwnfg 307t
10 Sep 20
Other Events
8:32am
8-K
s7q874muq7t
9 Sep 20
PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley Capital
8:32am
8-K
i2jsk
31 Aug 20
Amendments to Articles of Incorporation or Bylaws
9:38pm
8-K
czhhh2sao3fteylzpn
31 Aug 20
PDL BioPharma Announces Sale of Kybella®, Zalviso® and Coflex® Royalties
9:04am
8-K
sjvqpoid
28 Aug 20
PDL BioPharma Announces Offer to Purchase Convertible Notes Due 2021 and 2024
8:33am
8-K
ay6jvki16mf7x9rmsp
26 Aug 20
Other Events
9:02am
8-K
oteis 39bg
20 Aug 20
Departure of Directors or Certain Officers
5:06pm
8-K
rzhmk5
12 Aug 20
PDL BioPharma Enters Into Settlement Agreement with Wellstat
8:32am
8-K
4vmkpi
6 Aug 20
PDL BioPharma Reports 2020 Second Quarter Financial Results
4:07pm
8-K
gikhra0nl3ek5t9b02
30 Jul 20
PDL BioPharma Enters Into Agreement for the Divestiture of the Noden Pharmaceutical Business to Stanley Capital
8:44am
8-K
flr7qtxdviam7
28 Jul 20
Departure of Directors or Certain Officers
4:17pm
8-K
3l5neu
16 Jul 20
Results of Operations and Financial Condition
9:43pm
8-K
oos8w yh8uvblsghdhib
29 Jun 20
Other Events
12:00am
8-K
pdegbw xo9i
23 Jun 20
Other Events
4:05pm